Clarifies on News item
With reference to news appeared on : www.moneycontrol.com dated September 07, 2018 quoting "Sun Pharma falls 5% on report of co getting 6 observations by US FDA for Halol unit", Sun Pharmaceutical Industries Ltd has submitted to BSE a copy of Clarification is enclosed. Clarification sought from Sun Pharmaceutical Industries Ltd
The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on September 07, 2018 with reference to news appeared on : www.moneycontrol.com dated September 07, 2018 quoting "Sun Pharma falls 5% on report of co getting 6 observations by US FDA for Halol unit" The reply is awaited. Improved US prospects, domestic outlook to drive Sun Pharma's earnings
The key near-term trigger is the company's specialty pipeline Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper advertisement regarding i) Notice of the 26th Annual General Meeting of the Company to be held on Wednesday, September 26, 2018 for the financial year 2017-18, ii) E-voting and iii) Book Closure, in all the editions of Financial Express dated September 05, 2018 and in Ahmedabad Edition (Gujarati Language) of Financial Express dated September 05, 2018. Sun Pharma Advanced Research jumps nearly 5%
Shares of Sun Pharma Advanced Research Company (SPARC) jumped as much as 4.8 per cent to Rs 404.9, their biggest daily percentage gain in nearly a w Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Sudhir Valia - PAC Submission Of Notice Of Annual General Meeting To Be Held On September 26, 2018.
Pursuant to Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015, we are enclosing herewith Notice for the 26th Annual General Meeting of the shareholders of the Company, scheduled to be held on Wednesday, September 26, 2018 at 02.45 p.m. at Crystal Hall, Grand Mercure Vadodara Surya Palace, Opposite Parsi Agyari, Sayajigunj, Vadodara - 390 020, Gujarat, India, (a copy of which is being despatched/emailed to all... Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pratham Investments Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are pleased to enclose herewith our Press Release relating to Sun Pharma launching Volini Maxx, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you, US drug regulator inspects Sun Pharmaceutical's Halol plant in Gujarat
Sun Pharma had recalled around 5,000 units of 10 ml vials of testosterone cypionate injections from the US